Author:
Wang Xia,Yamamoto Yusuke,Wilson Lane H.,Zhang Ting,Howitt Brooke E.,Farrow Melissa A.,Kern Florian,Ning Gang,Hong Yue,Khor Chiea Chuen,Chevalier Benoit,Bertrand Denis,Wu Lingyan,Nagarajan Niranjan,Sylvester Francisco A.,Hyams Jeffrey S.,Devers Thomas,Bronson Roderick,Lacy D. Borden,Ho Khek Yu,Crum Christopher P.,McKeon Frank,Xian Wa
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Tabar, V. & Studer, L. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nature Rev. Genet. 15, 82–92 (2014)
2. Okano, H. & Yamanaka, S. iPS cell technologies: significance and applications to CNS regeneration and disease. Mol. Brain 7, 22 (2014)
3. Müller, A. M. & Dzierzak, E. A. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. Development 118, 1343–1351 (1993)
4. Helgason, C. D., Sauvageau, G., Lawrence, H. J., Largman, C. & Humphries, R. K. Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood 87, 2740–2749 (1996)
5. Bonde, S., Dowden, A. M., Chan, K. M., Tabayoyong, W. B. & Zavazava, N. HOXB4 but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cells. Transplantation 86, 1803–1809 (2008)